$0.11

+0.00 (+2.23%)

Weekly Expected Move ±12.8%

$0 $0 $0 $0 $0

OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 43 · $9.4M mcap · 57M float · 0.052% daily turnover · Short 24% of daily vol

Revenue

$7M +0.0% ▲

Gross Profit

$5M +0.0% ▲

Operating Income

-$10M +0.0% ▲

Net Income

-$15M +0.0% ▲

EPS (Diluted)

$-0.26 +0.0% ▲

EBITDA

-$6M +0.0% ▲

View Full Income Statement

Line Item	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3
Revenue	$63K	$263K	$159K	$93K	$92K
Cost of Revenue	$1K	$24K	$135K	$130K	$196K
Gross Profit	$62K	$239K	$23K	-$37K	-$104K
Gross Margin	98.4%	91.0%	14.7%	-39.2%	-113.8%
R&D Expenses	$3M	$3M	$2M	$2M	$3M
SG&A Expenses	$1M	$1M	$2M	$2M	$1M
Operating Expenses	$5M	$4M	$4M	$3M	$4M
Operating Income	-$5M	-$4M	-$3M	-$3M	-$5M
Operating Margin	-7347.6%	-1385.6%	-2196.3%	-3547.7%	-4918.5%
Interest Expense	$346K	-$2M	$240K	$243K	$225K
Income Before Tax	-$4M	-$5M	-$2M	-$3M	-$4M
Tax Expense	$0	$0	$0	$0	$0
Net Income	-$4M	-$5M	-$2M	-$3M	-$4M
Net Margin	-5652.4%	-1851.5%	-1240.8%	-3683.1%	-4867.7%
EPS (Diluted)	$-0.05	$-0.07	$-0.03	$-0.03	$-0.04
EBITDA	-$3M	-$5M	-$3M	-$3M	-$4M
Shares Outstanding	69M	69M	77M	100M	103M

CNVIF OTC